Literature DB >> 22154666

Electrophysiological impact of trazodone on the dopamine and norepinephrine systems in the rat brain.

Ramez Ghanbari1, Mostafa El Mansari, Pierre Blier.   

Abstract

Previous study has documented the long-term effects of the antidepressant trazodone on the serotonin (5-HT) system. The present work examined the impact of sustained trazodone on ventral tegmental area (VTA) dopamine (DA) and locus ceruleus (LC) norepinephrine (NE) neurons firing activity, and characterized its effects at 5-HT(2C), 5-HT(2A) receptors and α₁- and α₂-adrenoceptors. Electrophysiological recordings were carried out in anesthetized rats. Subcutaneously implanted minipumps delivered vehicle or trazodone (10 mg/kg/day) for 2 or 14 days. Administration of trazodone for 2 and 14 days did not alter the firing activity of DA neurons. Systemic injection of trazodone, however, reversed the inhibitory effect of the 5-HT(2C) receptor agonist Ro 60,0175 on the DA neuronal firing, suggesting an antagonistic action of trazodone at this receptor. Administration of trazodone for 2 days significantly enhanced the NE neurons firing. Despite a return of the NE neurons firing rate to the baseline following 14-day trazodone, the percentage of neurons discharging in burst was increased by this regimen. Administration of trazodone for 14 days enhanced the tonic activation of postsynaptic α₂-adrenoceptors, as indicated by the disinhibitory effect of the α₂-adrenoceptor antagonist idazoxan on hippocampus pyramidal neurons firing. The inhibitory effect of acute trazodone on dorsal raphe (DR) 5-HT neurons firing was shown to be through the 5-HT(1A) receptor. Systemic injection of trazodone reversed the inhibitory action of 5-HT(2A) agonist DOI on the NE neurons firing rate, indicating its antagonistic action at 5-HT(2A) receptors. The enhancement in α₂-adrenergic transmission by trazodone, and its 5-HT(2A) and 5-HT(2C) receptor antagonism may contribute to its therapeutic action in major depression.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22154666     DOI: 10.1016/j.euroneuro.2011.11.005

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  4 in total

1.  Brexpiprazole Alters Monoaminergic Systems following Repeated Administration: an in Vivo Electrophysiological Study.

Authors:  Chris A Oosterhof; Mostafa El Mansari; Christoffer Bundgaard; Pierre Blier
Journal:  Int J Neuropsychopharmacol       Date:  2015-10-01       Impact factor: 5.176

2.  Dual inhibitory action of trazodone on dorsal raphe serotonergic neurons through 5-HT1A receptor partial agonism and α1-adrenoceptor antagonism.

Authors:  Alberto Montalbano; Boris Mlinar; Francesco Bonfiglio; Lorenzo Polenzani; Maurizio Magnani; Renato Corradetti
Journal:  PLoS One       Date:  2019-09-26       Impact factor: 3.240

3.  Attempting to Increase the Effectiveness of the Antidepressant Trazodone Hydrochloride Drug Using π-Acceptors.

Authors:  Walaa F Alsanie; Majid Alhomrani; Abdulhakeem S Alamri; Hussain Alyami; Sonam Shakya; Hamza Habeeballah; Heba A Alkhatabi; Raed I Felimban; Abdulwahab Alamri; Abdulhameed Abdullah Alhabeeb; Bassem M Raafat; Moamen S Refat; Ahmed Gaber
Journal:  Int J Environ Res Public Health       Date:  2022-09-08       Impact factor: 4.614

4.  Computational Model of Antidepressant Response Heterogeneity as Multi-pathway Neuroadaptation.

Authors:  Mariam B Camacho; Thomas J Anastasio
Journal:  Front Pharmacol       Date:  2017-12-20       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.